Family Planning and Rheumatoid Arthritis.

IF 5.7 2区医学 Q1 RHEUMATOLOGY

Current Rheumatology Reports Pub Date : 2025-05-29 DOI:10.1007/s11926-025-01191-y

Catherine Sims, Mehret Birru Talabi

{"title":"Family Planning and Rheumatoid Arthritis.","authors":"Catherine Sims, Mehret Birru Talabi","doi":"10.1007/s11926-025-01191-y","DOIUrl":null,"url":null,"abstract":"Purpose of review: Patients with rheumatoid arthritis (RA) need tailored guidance when it comes to family planning decisions, including contraception, pregnancy, and breastfeeding. To achieve the best reproductive health outcomes, a coordinated, multidisciplinary approach is essential. This article aims to support healthcare providers in addressing key reproductive health concerns for both male and female patients, such as timing conception, infertility, and the management of RA medications during pregnancy and lactation.Recent findings: Some women with RA may experience subfertility, however assisted reproductive technology is a safe option. RA disease activity may change for some women during pregnancy, but this is influenced by disease activity going into pregnancy and medication use in pregnancy. Pregnancy complications are more common among women with RA compared to the general population, which may be explained, in part, by disease activity, extra-articular manifestations of RA, and/or use of certain medications. Neonates exposed to biologic medications in utero can receive all recommended vaccinations. Contraception, including emergency contraception, is safe for women with RA. Preliminary data suggests pregnancy termination is safe in women with RA and does not increase the risk for disease flare. RA is a chronic inflammatory disease that can impact both women and men during their reproductive years. Rheumatologists have an essential role in patient's reproductive health and family planning. This article highlights key considerations and offers strategies to assist providers in understanding and supporting their patients' reproductive goals.","PeriodicalId":10761,"journal":{"name":"Current Rheumatology Reports","volume":"27 1","pages":"26"},"PeriodicalIF":5.7000,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Rheumatology Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11926-025-01191-y","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose of review: Patients with rheumatoid arthritis (RA) need tailored guidance when it comes to family planning decisions, including contraception, pregnancy, and breastfeeding. To achieve the best reproductive health outcomes, a coordinated, multidisciplinary approach is essential. This article aims to support healthcare providers in addressing key reproductive health concerns for both male and female patients, such as timing conception, infertility, and the management of RA medications during pregnancy and lactation.

Recent findings: Some women with RA may experience subfertility, however assisted reproductive technology is a safe option. RA disease activity may change for some women during pregnancy, but this is influenced by disease activity going into pregnancy and medication use in pregnancy. Pregnancy complications are more common among women with RA compared to the general population, which may be explained, in part, by disease activity, extra-articular manifestations of RA, and/or use of certain medications. Neonates exposed to biologic medications in utero can receive all recommended vaccinations. Contraception, including emergency contraception, is safe for women with RA. Preliminary data suggests pregnancy termination is safe in women with RA and does not increase the risk for disease flare. RA is a chronic inflammatory disease that can impact both women and men during their reproductive years. Rheumatologists have an essential role in patient's reproductive health and family planning. This article highlights key considerations and offers strategies to assist providers in understanding and supporting their patients' reproductive goals.

查看原文本刊更多论文

计划生育与类风湿性关节炎。

综述目的：类风湿性关节炎（RA）患者在计划生育决策方面需要量身定制的指导，包括避孕、怀孕和母乳喂养。为了取得最佳的生殖健康成果，必须采取协调的多学科办法。本文旨在支持医疗保健提供者解决男性和女性患者的关键生殖健康问题，如受孕时机、不孕症以及妊娠和哺乳期RA药物管理。最近的研究发现：一些患有类风湿性关节炎的女性可能会经历生育能力低下，然而辅助生殖技术是一种安全的选择。一些妇女在怀孕期间类风湿性关节炎的疾病活动可能会发生变化，但这受到怀孕期间疾病活动和怀孕期间药物使用的影响。与一般人群相比，妊娠并发症在RA患者中更为常见，部分原因可能是疾病活动性、RA的关节外表现和/或某些药物的使用。在子宫内接触生物药物的新生儿可以接受所有推荐的疫苗接种。避孕，包括紧急避孕，对患有类风湿性关节炎的妇女是安全的。初步数据表明，终止妊娠对RA患者是安全的，不会增加疾病爆发的风险。类风湿性关节炎是一种慢性炎症性疾病，可影响育龄期的女性和男性。风湿病学家在患者的生殖健康和计划生育方面发挥着重要作用。这篇文章强调了关键的考虑因素，并提供了策略，以帮助提供者理解和支持他们的病人的生殖目标。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Rheumatology Reports RHEUMATOLOGY-

CiteScore

11.20

自引率

0.00%

发文量

期刊介绍： This journal aims to review the most important, recently published research in the field of rheumatology. By providing clear, insightful, balanced contributions by international experts, the journal intends to serve all those involved in the care and prevention of rheumatologic conditions. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas such as the many forms of arthritis, osteoporosis and metabolic bone disease, and systemic lupus erythematosus. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also occasionally provided.